中国医药导报
中国医药期刊欢迎您 今天是   2025年4月8日星期二
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报
  论著 本期目录 | 过刊浏览 | 高级检索 |
miR-16对人乳腺癌细胞MDA-MB-231增殖和凋亡的作用及机制
刘嘉祺  周福波  林峰  付惠
牡丹江医学院药理教研室,黑龙江牡丹江   157011
Effect and mechanism of miR-16 on proliferation and apoptosis of human breast cancer cells MDA-MB-231
LIU Jiaqi   ZHOU Fubo   LIN Feng   FU Hui
Department of Pharmacology, Mudanjiang Medical University, Heilongjiang Province, Mudanjiang   157011, China
全文: PDF (1035 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探究miR-16对人乳腺癌细胞MDA-MB-231增殖和凋亡的作用及机制。 方法 体外培养细胞,分组如下:人乳腺上皮细胞HBL-100(HBL-100组)和人乳腺癌细胞MDA-MB-231(MDA-MB-231组)。采用荧光实时定量PCR检测miR-16表达,蛋白质印迹法检测β2肾上腺素受体(β2-AR)蛋白表达。细胞瞬时转染,分组如下:MDA-MB-231组,MDA-MB-231+miR-16拟似物(miR-16 mimics组),MDA-MB-231+miR-16抑制物(miR-16 inhibitor组),MDA-MB-231+阴性对照(阴性对照组)。MTT比色法和Annexin V-FITC双染流式细胞仪检测观察miR-16对MDA-MB-231细胞增殖和凋亡影响。双萤光素酶报告基因验证miR-16与β2-AR靶向关系。 结果 MDA-MB-231组miR-16表达低于HBL-100组,β2-AR蛋白表达高于HBL-100组,差异有统计学意义(P<0.05)。MDA-MB-231组与阴性对照组细胞增殖比较,差异无统计学意义(P>0.05)。miR-16 mimics组细胞增殖低于MDA-MB-231组,miR-16 inhibitor组细胞增殖高于MDA-MB-231组,差异有统计学意义(P<0.05)。MDA-MB-231组与阴性对照组细胞凋亡率比较,差异无统计学意义(P>0.05)。miR-16 mimics组细胞凋亡率高于MDA-MB-231组,miR-16 inhibitor组细胞凋亡率低于MDA-MB-231组,差异有高度统计学意义(P<0.01)。双萤光素酶报告基因结果显示,与MDA-MB-231组比较,miR-16 inhibitor组和阴性对照组萤光素酶活性都没有明显变化,差异无统计学意义(P>0.05)。与MDA-MB-231组比较,具有β2-AR的3’UTR序列的miR-16 mimics组细胞的萤光素酶活性降低,差异有高度统计学意义(P<0.01);与MDA-MB-231组比较,具有突变的β2-AR的3’UTR序列的miR-16 mimics组细胞萤光素酶活性无明显改变,差异无统计学意义(P>0.05)。 结论 miR-16可能通过靶向β2-AR调控乳腺癌细胞增殖与凋亡。

服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
刘嘉祺  周福波  林峰  付惠
关键词 miR-16&beta2肾上腺素受体MDA-MB-231增殖凋亡    
Abstract:Objective To investigate the effect and mechanism of miR-16 on proliferation and apoptosis of human breast cancer cells MDA-MB-231. Methods The cells cultured in vitro were divided into the following groups: human mammary epithelial cells HBL-100 (HBL-100 group ) and human breast cancer cells MDA-MB-231 (MDA-MB-231 group ). Real-time fluorescent quantitative PCR was used to detect miR-16 expression, and Western blot was used to detect β2 adrenergic receptor (β2-AR) protein expression. Transient transfection of cells was grouped as follows: MDA-MB-231 group, MDA-MB-231+miR-16 mimics (miR-16 mimics group), MDA-MB-231+miR-16 inhibitor (miR-16 inhibitor group), MDA-MB-231+ negative control (negative control group). The effects of miR-16 on proliferation and apoptosis of MDA-MB-231 cells were observed by MTT colorimetry and Annexin V-FITC double dye flow cytometry. The targeting relationship between miR-16 and β2-AR was verified by dual luciferase reporter genes. Results The expression of miR-16 in MDA-MB-231 group was lower than that in HBL-100 group, and the expression of β2-AR protein was higher than that in HBL-100 group, and the differences were statistically significant (P<0.05). There was no significant difference in cell proliferation between MDA-MB-231 group and negative control group (P>0.05). Cell proliferation in miR-16 mimics group was lower than that in MDA-MB-231 group, and cell proliferation in miR-16 inhibitor group was higher than that in MDA-MB-231 group, and the differences were statistically significant (P<0.05). There was no significant difference in apoptosis rate between MDA-MB-231 group and negative control group (P>0.05). The apoptosis rate in miR-16 mimics group was higher than that in MDA-MB-231 group, and the apoptosis rate in miR-16 inhibitor group was lower than that in MDA-MB-231 group, and the differences were highly statistically significant (P<0.01). The results of dual luciferase reporter gene showed that, compared with MDA-MB-231 group, luciferase activity in miR-16 inhibitor group and negative control group had no significant changes, with no statistical significance (P>0.05). Compared with MDA-MB-231 group, the luciferase activity of miR-16 mimics group with β2-AR 3’UTR sequence decreased, the difference was highly statistically significant (P<0.01). Compared with MDA-MB-231 group, there was no significant change in luciferase activity in miR-16 mimics group with mutated β2-AR 3’UTR sequence, with no statistical significance (P>0.05). Conclusion miR-16 may regulate the proliferation and apoptosis of breast cancer cells by targeting β2-AR.
Key wordsmiR-16    β2-adrenergic receptor    MDA-MB-231    Proliferation    Apoptosis
    
基金资助:黑龙江省省属高校基本科研业务费项目(2018-KYYWF-0144)
作者简介: 刘嘉祺(1981-),女,博士,主要从事药理学教学与科研工作。
引用本文:   
刘嘉祺  周福波  林峰  付惠. miR-16对人乳腺癌细胞MDA-MB-231增殖和凋亡的作用及机制[J]. 中国医药导报, 2023, 20(25): 38-42.
LIU Jiaqi ZHOU Fubo LIN Feng FU Hui. Effect and mechanism of miR-16 on proliferation and apoptosis of human breast cancer cells MDA-MB-231. 中国医药导报, 2023, 20(25): 38-42.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/10.20047/j.issn1673-7210.2023.25.06     或     https://www.yiyaodaobao.com.cn/CN/Y2023/V20/I25/38

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司